EP4291260A1 - Urinary catheter kit - Google Patents
Urinary catheter kitInfo
- Publication number
- EP4291260A1 EP4291260A1 EP22704389.0A EP22704389A EP4291260A1 EP 4291260 A1 EP4291260 A1 EP 4291260A1 EP 22704389 A EP22704389 A EP 22704389A EP 4291260 A1 EP4291260 A1 EP 4291260A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- copolymer
- thermogelling
- urinary catheter
- kit
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002485 urinary effect Effects 0.000 title claims abstract description 38
- 229920001577 copolymer Polymers 0.000 claims abstract description 90
- 239000000203 mixture Substances 0.000 claims abstract description 53
- 239000000314 lubricant Substances 0.000 claims abstract description 40
- 238000000576 coating method Methods 0.000 claims abstract description 22
- 239000011248 coating agent Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 125000001033 ether group Chemical group 0.000 claims abstract description 10
- 229920002635 polyurethane Polymers 0.000 claims abstract description 7
- 239000004814 polyurethane Substances 0.000 claims abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- 238000007598 dipping method Methods 0.000 claims description 7
- 230000001050 lubricating effect Effects 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229920001451 polypropylene glycol Polymers 0.000 claims description 6
- 125000004185 ester group Chemical group 0.000 claims description 4
- 239000012815 thermoplastic material Substances 0.000 claims description 4
- 238000001125 extrusion Methods 0.000 claims description 2
- 239000011247 coating layer Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 claims 1
- -1 poly(ethylene oxide) Polymers 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 5
- 238000007605 air drying Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 3
- 210000003708 urethra Anatomy 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
Definitions
- This invention concerns the field of urinary catheters and, in particular, that of packaged urinary catheters.
- Urinary catheters are available on the market in various configurations. They are used both in clinical settings and by patients themselves in daily life and in non-sterile environments. The packaging is subject to various requirements that the urinary catheters that have been available to date only partially satisfy.
- Catheters are placed either for extended periods of time, e.g. in clinical applications in the case of operations, or intermittently, several times a day, for urination, as in the case of patients with paraplegia.
- Catheters normally consist of a tubular part that is thin and flexible, with a rounded end, and, most of the time, have lateral openings in the wall such that the end of the catheter can be inserted into the bladder via the urethra, with the lateral openings allowing urine to pass through the catheter and exit the body.
- a drainage bag or a connector allowing for connection to a drainage bag, usually with a handle at the end of the catheter in order to facilitate the manipulation of the catheter during its insertion into the urethra and its connection to a drainage bag.
- Catheters may be coated with a lubricant to ease their insertion into the urethra.
- catheters There are generally two types of catheters:
- the second category of catheters avoids this issue of activation and splashing, but the catheter generally does not glide as smoothly as catheters with water- activated coatings.
- An object of this invention is thus to provide a ready-to-use urinary catheter kit that is easy to prepare, for a single use, and that is able to glide more smoothly.
- this invention concerns a urinary catheter kit comprising: an aqueous lubricant composition comprising water and at least one polyether- polyurethane P1 thermogelling copolymer, and a urinary catheter with an external coating of thermogelling copolymer P2 comprising at least ether units.
- the urinary catheter is immersed in the aqueous lubricant composition.
- thermogelling copolymer P2 comprises at least some ether units and units selected from urethane units, ester units, and mixtures thereof, preferably urethane units.
- thermogelling copolymer P1 and the thermogelling copolymer P2 have a viscosity of 5 - 100 mPa.s, preferably 10 - 80 mPa.s, at 25°C.
- thermogelling copolymer P1 and the thermogelling copolymer P2 comprise poly(ethylene oxide) and polypropylene oxide) units.
- thermogelling copolymer P1 has a poly(ethylene oxide) content of 50 - 99 wt %, preferably 70 - 95 wt %, more preferably 75 - 90 wt %, based on the total weight of the copolymer.
- the aqueous lubricant composition comprises from 1 to 20% by dry weight, preferably from 2 to 15% by dry weight, more preferably from 3 to 10% by dry weight, of thermogelling copolymer(s) P1, based on the total weight of the aqueous lubricating composition.
- the aqueous lubricant composition further comprises glycerin, preferably in an amount of from 1 to 30% by weight, preferably from 5 to 25% by weight, more preferably from 10 to 20% by weight, based on the total weight of the aqueous lubricating composition.
- the copolymer coating is applied by dipping and drying the catheter in a composition comprising the thermogelling copolymer P2.
- thermogelling copolymer coating P2 is applied by extruding a composition comprising the thermogelling copolymer P2.
- the catheter has two layers, preferably identical, of thermogelling copolymer coating P2.
- thermogelling copolymer comprising at least some ether units, as a coating for a urinary catheter, in a urinary catheter kit in order to reduce the friction coefficient of the catheter.
- the two copolymers P1 and P2 are two thermogelling copolymers.
- the two copolymers P1 and P2 may be identical or different.
- Thermogelling polymer refers to a polymer that is typically liquid at room temperature (app. 22 °C) and that can transition to the gel state when the temperature increases.
- thermogelling copolymers P1 and P2 used in the invention have a viscosity at least 10 times greater at 37 °C than at 25 °C.
- thermogelling copolymers used in the invention will be reached at 37 °C.
- the two copolymers P1 and P2 may have identical or different viscosities.
- thermogelling copolymer P1 and the thermogelling copolymer P2 comprise at least one linear chain comprising ether units.
- thermogelling copolymers (P1 and P2) used in the invention may be as described in document FR2840907.
- the thermogelling copolymers (P1 and P2) are commercially available, e.g. at PolymerExpert.
- the aqueous lubricant composition comprises from 1 to 20% by dry weight, preferably from 2 to 15% by dry weight, more preferably from 3 to 10% by dry weight, of thermogelling copolymer(s) P1, based on the total weight of the aqueous lubricating composition.
- the aqueous lubricant composition further comprises glycerine, preferably in an amount of from 1 to 30% by weight, preferably from 5 to 25% by weight, more preferably from 10 to 20% by weight, based on the total weight of the aqueous lubricating composition.
- thermogelling copolymer P2 The catheter used according to the invention is coated on the outside with a thermogelling copolymer P2.
- the thermogelling copolymer P2 maybe identical or different to the thermogelling copolymer P1.
- each layer may be applied by carrying out a cycle of dipping in a thermogelling copolymer solution, followed by drying, with that cycle being repeated as many times as layers of coating are applied.
- the initial uncoated catheter is made of thermoplastic olefinic (TPO) material.
- the initial uncoated catheter in particular when it is made of TPO, is previously activated, e.g. by plasma, and/or coated with a primer, before being coated with the thermogelling copolymer.
- the primer will typically have a chemical affinity with the material of the uncoated catheter, e.g. TPO, which will facilitate the engraftment of the thermogelling copolymer onto the catheter.
- the primer may comprise a poly(meth)acrylate copolymer.
- the catheter is activated by plasma treatment, then the catheter thus activated is dipped into a primer solution and then dried, preferably air-dried, under laminar flow or in a heated environment.
- the invention also concerns the combined use of a lubricant composition according to the invention and a catheter coating according to the invention in order to improve the smooth gliding of the catheter.
- the friction coefficient is reduced due to the combination of a lubricant composition as defined according to the invention and an outer catheter coating as defined according to the invention.
- the urinary catheter kit according to the invention allows the urinary catheter to attain a friction coefficient of less than 0.1.
- the sample is placed between the jaws and attached to the traction cell.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2101386A FR3119776B1 (fr) | 2021-02-12 | 2021-02-12 | Kit de sonde urinaire |
PCT/EP2022/053272 WO2022171749A1 (en) | 2021-02-12 | 2022-02-10 | Urinary catheter kit |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4291260A1 true EP4291260A1 (en) | 2023-12-20 |
Family
ID=75850289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22704389.0A Pending EP4291260A1 (en) | 2021-02-12 | 2022-02-10 | Urinary catheter kit |
Country Status (8)
Country | Link |
---|---|
US (1) | US20240082464A1 (pt) |
EP (1) | EP4291260A1 (pt) |
JP (1) | JP2024508626A (pt) |
CN (1) | CN116867524A (pt) |
BR (1) | BR112023014974A2 (pt) |
CA (1) | CA3209563A1 (pt) |
FR (1) | FR3119776B1 (pt) |
WO (1) | WO2022171749A1 (pt) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4412754C2 (de) * | 1994-04-13 | 1999-09-30 | Via Log Medikalprodukte Gmbh K | Verpackung eines medizinischen Instruments |
FR2840907B1 (fr) | 2002-06-14 | 2005-11-25 | Polymerexpert Sa | Polymere thermo-sensible ameliore susceptible de former des gels thermoreversibles a haut indice de viscosification |
CN106967206B (zh) * | 2017-04-12 | 2018-02-09 | 沈坤 | 亲水润滑医用聚氨酯材料及其制备方法和应用 |
-
2021
- 2021-02-12 FR FR2101386A patent/FR3119776B1/fr active Active
-
2022
- 2022-02-10 WO PCT/EP2022/053272 patent/WO2022171749A1/en active Application Filing
- 2022-02-10 JP JP2023545799A patent/JP2024508626A/ja active Pending
- 2022-02-10 US US18/263,079 patent/US20240082464A1/en active Pending
- 2022-02-10 EP EP22704389.0A patent/EP4291260A1/en active Pending
- 2022-02-10 CA CA3209563A patent/CA3209563A1/en active Pending
- 2022-02-10 CN CN202280011504.6A patent/CN116867524A/zh active Pending
- 2022-02-10 BR BR112023014974A patent/BR112023014974A2/pt unknown
Also Published As
Publication number | Publication date |
---|---|
JP2024508626A (ja) | 2024-02-28 |
WO2022171749A1 (en) | 2022-08-18 |
FR3119776B1 (fr) | 2023-04-28 |
CA3209563A1 (en) | 2022-08-18 |
BR112023014974A2 (pt) | 2023-11-07 |
FR3119776A1 (fr) | 2022-08-19 |
US20240082464A1 (en) | 2024-03-14 |
CN116867524A (zh) | 2023-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020233713B2 (en) | Hydrophilic coatings and methods of forming the same | |
EP2392362B1 (en) | Medical device which has lubricating surface when wet | |
JPH02147694A (ja) | 血液適合性の潤滑性物品ならびにそれに用いる組成物および方法 | |
AU2017223298B2 (en) | Medical device with hydrophilic coating | |
AU2018209951B2 (en) | Method for sterilizing a substrate having a hydrophilic coating and sterilized substrates | |
US9867907B2 (en) | Self-lubricated catheters | |
AU2019366891A1 (en) | Hydrophilic coatings for medical devices | |
EP4291260A1 (en) | Urinary catheter kit | |
CN104984456A (zh) | 一种抗菌型聚氨酯类医疗器械、其制备方法及抗菌型留置针外周导管 | |
JP2004215710A (ja) | 潤滑性被膜剤および吸湿時に潤滑性を発現する医療用具 | |
EP4351688A1 (en) | Intermittent catheters and methods | |
CN114432504A (zh) | 一种表面处理组合物、具有该组合物的球囊微导管及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230905 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) |